Cerebrovascular pathology and Alzheimer’s disease

Por Nelson, Peter T
Publicado no Lancet Neurol (2016)

A permeation theory for single-file ion channels: One- and two-step models

Por Nelson, Peter Hugo
Publicado em 2011

Osmosis and thermodynamics explained by solute blocking

Por Nelson, Peter Hugo
Publicado no Eur Biophys J (2016)

Molecular Pathways: Involving Microenvironment Damage Responses in Cancer Therapy Resistance

Por Sun, Yu, Nelson, Peter S.
Publicado em 2012

Studying microRNAs in the brain: Technical lessons learned from the first ten years

Por Hébert, Sébastien S., Nelson, Peter T.
Publicado em 2011

The androgen/androgen receptor axis in prostate cancer

Por Bluemn, Eric, Nelson, Peter S.
Publicado em 2012

Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance

Por Levesque, Christine, Nelson, Peter S.
Publicado no Cold Spring Harb Perspect Med (2018)

Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications

Por Mostaghel, Elahe A., Nelson, Peter S.
Publicado em 2008

MiR-107 is reduced in Alzheimer’s disease brain neocortex: validation study

Por Nelson, Peter T., Wang, Wang-Xia
Publicado em 2010

In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brain

Por Nelson, Peter T., Wilfred, Bernard R.
Publicado em 2009

Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options

Por Jicha, Gregory A, Nelson, Peter T
Publicado em 2011

Cellular Senescence and Cancer Chemotherapy Resistance

Por Gordon, Ryan R., Nelson, Peter S.
Publicado em 2012

Membrane-anchored chemokine fusion proteins: A novel class of adjuvants for immunotherapy

Por Nelson, Peter J, Muenchmeier, Niklas
Publicado em 2013

Cerebrospinal Fluid Vascular Endothelial Growth Factor

Por Nelson, Peter T., Jicha, Gregory A.
Publicado no JAMA Neurol (2015)

Biomarkers and evolution in Alzheimer disease

Por Rapoport, Stanley I., Nelson, Peter T.
Publicado no Prog Neurobiol (2011)

Chemokines in Renal Diseases

Por Segerer, Stephan, Nelson, Peter J.
Publicado no ScientificWorldJournal (2005)

Therapeutics in Renal Disease: The Road Ahead for Antiproliferative Targets

Por Nelson, Peter J., Shankl, Stuart J.
Publicado em 2005

“High-tech” aids

Por Durie, Nelson D., Nelson, Peter J.
Publicado em 1983

Collapsing glomerulopathy: beyond serendipity in mouse genetics

Por Nelson, Peter J., Bruggeman, Leslie A.
Publicado em 2009

Controversies in the pathogenesis of HIV-associated renal diseases

Por Bruggeman, Leslie A., Nelson, Peter J.
Publicado em 2009